Literature DB >> 16183144

Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice.

Kelly K Anderson1, David A Ballok, Neena Prasad, Henry Szechtman, Boris Sakic.   

Abstract

Spontaneous development of lupus-like disease in MRL-lpr mice is accompanied by a constellation of behavioral deficits, including blunted responsiveness to sucrose. Although autoimmunity-induced damage of limbic areas is proposed to underlie this deficit, the systemic nature of the disease precludes inference of a causal relationship between CNS damage and functional loss. Based on the stimulatory effects of d-amphetamine sulfate (AMPH) on sucrose intake, the present study pharmacologically probes the functional status of central dopaminergic circuits involved in control of behavioral reward. The response rates were compared between diseased MRL-lpr mice and congenic MRL +/+ controls tested in the sucrose preference paradigm. Neuronal loss was assessed by Fluoro Jade B (FJB) staining of nucleus accumbens and the CA2/CA3 region. While control mice significantly increased intake of sucrose solutions 60 min after administration of AMPH (i.p., 0.5 mg/kg), the intake in drugged MRL-lpr mice was comparable to those given saline injection. Increased FJB staining was detected in the nucleus accumbens and hippocampus of diseased mice, and AMPH treatment neither altered this nor other measures of organ pathology. The results obtained are consistent with previously observed changes in the mesolimbic dopamine system of MRL-lpr mice and suggest that the lesion in the nucleus accumbens and deficits in dopamine release underlie impaired responsiveness to palatable stimulation during the progress of systemic autoimmune disease. As such, they point to a neurotransmitter-specific regional brain damage which may account for depressive behaviors in neuropsychiatric lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16183144      PMCID: PMC1634760          DOI: 10.1016/j.bbr.2005.07.030

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  72 in total

1.  Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices.

Authors:  R E Heikkila; H Orlansky; G Cohen
Journal:  Biochem Pharmacol       Date:  1975-04-15       Impact factor: 5.858

2.  Taste aversion learning in autoimmune Mrl-lpr/lpr and Mrl +/+ mice.

Authors:  L J Grota; R Ader; N Cohen
Journal:  Brain Behav Immun       Date:  1987-09       Impact factor: 7.217

3.  Age-associated increase in interleukin 6 in MRL/lpr mice.

Authors:  B Tang; T Matsuda; S Akira; N Nagata; S Ikehara; T Hirano; T Kishimoto
Journal:  Int Immunol       Date:  1991-03       Impact factor: 4.823

Review 4.  CNS injury: the role of the cytokine IL-1.

Authors:  Rosemary M Gibson; Nancy J Rothwell; Ros A Le Feuvre
Journal:  Vet J       Date:  2004-11       Impact factor: 2.688

5.  Effects of d- and l-amphetamine on food intake: evidence for a dopaminergic substrate.

Authors:  K R Evans; F J Vaccarino
Journal:  Pharmacol Biochem Behav       Date:  1987-08       Impact factor: 3.533

6.  Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: comparative histologic and immunohistochemical findings.

Authors:  C M Vogelweid; G C Johnson; C L Besch-Williford; J Basler; S E Walker
Journal:  J Neuroimmunol       Date:  1991-12       Impact factor: 3.478

7.  Autoimmune-induced damage of the midbrain dopaminergic system in lupus-prone mice.

Authors:  David A Ballok; Aoife M Earls; Catherine Krasnik; Steven A Hoffman; Boris Sakic
Journal:  J Neuroimmunol       Date:  2004-07       Impact factor: 3.478

8.  Prolactin influences autoimmune disease activity in the female B/W mouse.

Authors:  R McMurray; D Keisler; K Kanuckel; S Izui; S E Walker
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

9.  Hippocampal damage in mouse and human forms of systemic autoimmune disease.

Authors:  David A Ballok; John Woulfe; Monalisa Sur; Michael Cyr; Boris Sakic
Journal:  Hippocampus       Date:  2004       Impact factor: 3.899

10.  Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from the hypothalamus in vivo.

Authors:  P S Mohankumar; S Thyagarajan; S K Quadri
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

View more
  10 in total

Review 1.  Neuroimmunopathology in a murine model of neuropsychiatric lupus.

Authors:  David A Ballok
Journal:  Brain Res Rev       Date:  2006-12-20

2.  Fluoro-Jade B staining following zymosan microinjection into the spinal cord white matter.

Authors:  Kamila Saganová; Jozef Burda; Judita Orendácová; Dása Cízková; Ivo Vanický
Journal:  Cell Mol Neurobiol       Date:  2006-06-14       Impact factor: 5.046

3.  Prolactin has a pathogenic role in systemic lupus erythematosus.

Authors:  Luis J Jara; Gabriela Medina; Miguel A Saavedra; Olga Vera-Lastra; Honorio Torres-Aguilar; Carmen Navarro; Monica Vazquez Del Mercado; Luis R Espinoza
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

4.  Ibuprofen fails to prevent brain pathology in a model of neuropsychiatric lupus.

Authors:  David A Ballok; Xiaoxing Ma; Judah A Denburg; Larry Arsenault; Boris Sakic
Journal:  J Rheumatol       Date:  2006-11       Impact factor: 4.666

5.  Purine receptor antagonist modulates serology and affective behaviors in lupus-prone mice: evidence of autoimmune-induced pain?

Authors:  David A Ballok; Boris Sakic
Journal:  Brain Behav Immun       Date:  2008-06-14       Impact factor: 7.217

6.  Effects of prolonged treatment with memantine in the MRL model of CNS lupus.

Authors:  Katarina Marcinko; Tiffany Parsons; Jason P Lerch; John G Sled; Boris Sakic
Journal:  Clin Exp Neuroimmunol       Date:  2012-09

Review 7.  The role of tumor necrosis factor receptor superfamily members in mammalian brain development, function and homeostasis.

Authors:  Jason P Twohig; Simone M Cuff; Audrey A Yong; Eddie C Y Wang
Journal:  Rev Neurosci       Date:  2011-08-24       Impact factor: 4.353

Review 8.  The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.

Authors:  Maria Gulinello; Chaim Putterman
Journal:  J Biomed Biotechnol       Date:  2011-02-10

Review 9.  The dopaminergic system in autoimmune diseases.

Authors:  Rodrigo Pacheco; Francisco Contreras; Moncef Zouali
Journal:  Front Immunol       Date:  2014-03-21       Impact factor: 7.561

10.  Impaired decision-making and functional neuronal network activity in systemic lupus erythematosus.

Authors:  Bei-Bei Wu; Ye Ma; Lei Xie; Jin-Zhuang Huang; Zong-Bo Sun; Zhi-Duo Hou; Rui-Wei Guo; Zhi-Rong Lin; Shou-Xing Duan; Shan-Shan Zhao; Dan-Miao Sun; Chun-Min Zhu; Shu-Hua Ma
Journal:  J Magn Reson Imaging       Date:  2018-03-14       Impact factor: 4.813

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.